Added to YB: 2025-09-19
Pitch date: 2025-09-17
MEDP [bullish]
Medpace Holdings, Inc.
+11.06%
current return
Author Info
No bio for this author
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
Market Cap
$15.4B
Pitch Price
$502.32
Price Target
N/A
Dividend
N/A
EV/EBITDA
26.28
P/E
38.18
EV/Sales
6.44
Sector
Life Sciences Tools and Services
Category
growth
Through the Lens of the CEO: Medpace Holdings — How $913M in Stock Repurchases Reflects Our Operational Strength
MEDP: Q2 revenue $603M (+14.2% YOY), EBITDA $130M (21.6% margin). Aggressive $518M share buybacks left only $46M cash vs $669M year-end. 2025 guidance $2.42-2.52B revenue (+14.7-19.5%), EPS up to $14.53 vs $13.04 prior. Integrated CRO model drives superior execution, client stickiness & margin expansion while competitors struggle with integration costs.
Read full article (7 min)